PropertyValue
?:abstract
  • The current COVID-19 pandemic requires urgent development of effective therapeutics. 5-amino levulinic acid (5-ALA) is a naturally synthesized amino acid and has been used for multiple purposes including as an anticancer therapy and as a dietary supplement due to its high bioavailability. In this study, we demonstrated that 5-ALA treatment potently inhibited infection of SARS-CoV-2, a causative agent of COVID-19. The antiviral effects could be detected in both human and non-human cells, without significant cytotoxicity. Therefore, 5-ALA is a candidate as an oral antiviral drug for COVID-19.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1101/2020.10.28.355305
?:externalLink
?:journal
  • bioRxiv
?:license
  • biorxiv
?:pdf_json_files
  • document_parses/pdf_json/0957281efdf8d4d7fbcb9d366495fb6a6ee7c621.json
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • BioRxiv; WHO
?:title
  • 5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro
?:type
?:year
  • 2020-10-28

Metadata

Anon_0  
expand all